Anbio Biotechnology Cl A
(NNNN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | |
| Sales | 8,185 | 6,712 | 23,545 |
| Cost of Goods | 2,300 | 3,351 | 10,981 |
| Gross Profit | 5,885 | 3,361 | 12,564 |
| Operating Expenses | 4,190 | 1,751 | 3,349 |
| Operating Income | 1,995 | 1,961 | 10,196 |
| Interest Expense | 0 | 0 | 8 |
| Other Income | 377 | 293 | -176 |
| Pre-tax Income | 2,373 | 2,254 | 10,011 |
| Net Income Continuous | 2,373 | 2,254 | 10,011 |
| Net Income | $2,373 | $2,254 | $10,011 |
| EPS Basic Total Ops | 0.06 | 0.11 | 100,112.00 |
| EPS Basic Continuous Ops | 0.06 | 0.11 | 100,111.80 |
| EPS Diluted Total Ops | 0.06 | 0.11 | 100,112.00 |
| EPS Diluted Continuous Ops | 0.06 | 0.11 | 100,111.80 |
| EPS Diluted Before Non-Recurring Items | 0.06 | N/A | N/A |
| EBITDA(a) | $1,995 | $1,961 | $10,196 |